The new National Cholesterol Education Program guidelines: clinical challenges for more widespread therapy of lipids to treat and prevent coronary heart disease.
Eidelman
Rachel S
RS
Mount Sinai Medical Center, Cardiology Research, 4300 Alton Rd, Suite 207A, Miami Beach, FL 33140, USA.
Lamas
Gervasio A
GA
Hennekens
Charles H
CH
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000191:economics / Q000627:therapeutic use*; D008403:Mass Screening; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000592:standards*; D018570:Risk Assessment; D014481:United States
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents